Real time qPCR analyses of alpha fetoprotein (AFP), HCC tumor marker, showed a reduced expression in all treated groups compared to the control (Figure 2F), with a much stronger effect in the combination group (p=0.0138). This evidence concerns the gene AFP and hepatocellular carcinoma.